News 腸内マイクロバイオームへの薬物投与 2015年3月1日 Nature Biotechnology 33, 3 doi: 10.1038/nbt.3161 Using conventional drug discovery and novel synthetic biology approaches, some investigators and companies are mining our resident microbes and their metabolites for targets in small-molecule drug programs. Ken Garber reports. Full text PDF 目次へ戻る
